Literature DB >> 2052707

Multiple giant cell tumors and Paget disease of bone: radiographic and clinical correlations.

H G Potter1, R Schneider, B Ghelman, J H Healey, J M Lane.   

Abstract

The clinical and radiographic findings of four patients with multicentric giant cell tumor (GCT) of bone and Paget disease were retrospectively reviewed. Three patients underwent magnetic resonance (MR) imaging evaluation; all patients underwent computed tomography (CT). The MR characteristics of the bone component in pagetic GCT appeared to reflect the pagetic phase; a sclerotic pattern was largely represented by hypointense marrow signal intensity on images obtained with both long and short repetition times (TRs) and echo times (TEs). Conversely, a tumor appearing in a mixed pagetic phase demonstrated more heterogeneous signal intensity with all pulse sequences. Extensive soft-tissue components, noted in all cases, showed largely intermediate signal intensity on short TR/TE images and foci of increased signal intensity on longer TR/TE images. In most cases, dramatic reduction in tumor bulk was noted with the use of steroids alone. An awareness of this entity is important because the appearance of lytic lesions with soft-tissue extension in patients with Paget disease does not necessarily imply a grave prognosis. Serial CT or MR imaging is helpful in monitoring the remissions and exacerbations that reflect response to therapy in Paget disease and GCT.

Entities:  

Mesh:

Year:  1991        PMID: 2052707     DOI: 10.1148/radiology.180.1.2052707

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

1.  Subperiosteal ganglion associated with Paget's disease of bone.

Authors:  R Mansour; M Nanni; T Muthukumar; S H Butt; V N Cassar-Pullicino
Journal:  Skeletal Radiol       Date:  2004-10-26       Impact factor: 2.199

Review 2.  The contribution of Sir James Paget (1814-1894) to the study of rheumatic disease.

Authors:  W Buchanan
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

3.  The hypermetabolic giant: 18F-FDG avid giant cell tumor identified on PET-CT.

Authors:  Wendi O'Connor; Megan Quintana; Scott Smith; Monte Willis; Jordan Renner
Journal:  J Radiol Case Rep       Date:  2014-06-30

4.  Giant-cell-rich pseudotumour in Paget's disease.

Authors:  N M Gamage; T G Kashima; M A McNally; C L M H Gibbons; R Smith; S J Ostlere; N A Athanasou
Journal:  Skeletal Radiol       Date:  2012-12-29       Impact factor: 2.199

5.  Multicentric giant cell tumor of skeleton.

Authors:  P Bacchini; F Bertoni; P Ruggieri; M Campanacci
Journal:  Skeletal Radiol       Date:  1995-07       Impact factor: 2.199

6.  Case report 862: Multiple giant cell tumor of bone (symmetrical lesions in both humeral heads).

Authors:  Y Ogihara; A Sudo; Y Shiokawa; K Takeda; I Kusano
Journal:  Skeletal Radiol       Date:  1994-08       Impact factor: 2.199

7.  Primary thoracic giant cell tumor of bone sensitive to steroids.

Authors:  Huiliang Yang; Gi Hye Im; Gunnlaugur Petur Nielsen; Arvin Kheterpal; Joseph H Schwab
Journal:  Skeletal Radiol       Date:  2018-03-03       Impact factor: 2.199

8.  Giant cell tumor in a case of Paget's disease of bone: an aggressive benign tumor exhibiting a quick response to an innovative therapeutic agent.

Authors:  Roberta Cosso; Vincenzo Nuzzo; Alfonso Zuccoli; Maria Luisa Brandi; Alberto Falchetti
Journal:  Clin Cases Miner Bone Metab       Date:  2010-05

Review 9.  Neoplastic transformation and tumour-like lesions in Paget's disease of bone: a pictorial review.

Authors:  C López; D V Thomas; A M Davies
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

10.  Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy.

Authors:  D Rendina; F Gianfrancesco; G De Filippo; D Merlotti; T Esposito; A Aloia; D Benvenuto; C L Vivona; G Annunziata; R Nuti; P Strazzullo; G Mossetti; L Gennari
Journal:  J Endocrinol Invest       Date:  2009-12-22       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.